DOI QR코드

DOI QR Code

Proteomic Analysis of Colonic Mucosal Tissue from Tuberculous and Ulcerative Colitis Patients

  • Kwon, Seong-Chun (Department of Physiology, Kwandong University College of Medicine) ;
  • Won, Kyung-Jong (Department of Physiology, School of Medicine, Konkuk University) ;
  • Jung, Seoung-Hyo (Department of Physiology, School of Medicine, Konkuk University) ;
  • Lee, Kang-Pa (Department of Physiology, School of Medicine, Konkuk University) ;
  • Lee, Dong-Youb (Department of Physiology, School of Medicine, Konkuk University) ;
  • Park, Eun-Seok (Department of Physiology, School of Medicine, Konkuk University) ;
  • Kim, Bok-Yung (Department of Physiology, School of Medicine, Konkuk University) ;
  • Cheon, Gab-Jin (Department of Internal Medicine, University of Ulsan College of Medicine, Gangneung Asan Hospital) ;
  • Han, Koon-Hee (Department of Internal Medicine, University of Ulsan College of Medicine, Gangneung Asan Hospital)
  • Received : 2012.03.15
  • Accepted : 2012.06.08
  • Published : 2012.06.30

Abstract

Changes in the expression profiles of specific proteins leads to serious human diseases, including colitis. The proteomic changes related to colitis and the differential expression between tuberculous (TC) and ulcerative colitis (UC) in colon tissue from colitis patients has not been defined. We therefore performed a proteomic analysis of human TC and UC mucosal tissue. Total protein was obtained from the colon mucosal tissue of normal, TC, and UC patients, and resolved by 2-dimensional electrophoresis (2-DE). The results were analyzed with PDQuest using silver staining. We used matrix-assisted laser desorption ionization time-of-flight/time-of-flight spectrometry (MALDI TOF/TOF) to identify proteins differentially expressed in TC and UC. Of the over 1,000 proteins isolated, three in TC tissue and two in UC tissue displayed altered expression when compared to normal tissue. Moreover, two proteins were differentially expressed in a comparative analysis between TC and UC. These were identified as mutant ${\beta}$-actin, ${\alpha}$-enolase and Charcot-Leyden crystal protein. In particular, the expression of ${\alpha}$-enolase was significantly greater in TC compared with normal tissue, but decreased in comparison to UC, implying that ${\alpha}$-enolase may represent a biomarker for differential diagnosis of TC and UC. This study therefore provides a valuable resource for the molecular and diagnostic analysis of human colitis.

Keywords

References

  1. Horn AE, Ufberg JW. Appendicitis, diverticulitis, and colitis. Emerg Med Clin North Am. 2011;29:347-368. https://doi.org/10.1016/j.emc.2011.01.002
  2. Rasheed S, Zinicola R, Watson D, Bajwa A, McDonald PJ. Intra-abdominal and gastrointestinal tuberculosis. Colorectal Dis. 2007;9:773-783. https://doi.org/10.1111/j.1463-1318.2007.01337.x
  3. Brenner SM, Annes G, Parker JG. Tuberculous colitis simulating nonspecific granulomatous disease of the colon. Am J Dig Dis. 1970;15:85-92. https://doi.org/10.1007/BF02239351
  4. Danese S, Fiocchi C. Ulcerative colitis. N Engl J Med. 2011;365:1713-1725. https://doi.org/10.1056/NEJMra1102942
  5. Page MJ, Amess B, Rohlff C, Stubberfield C, Parekh R. Proteomics: a major new technology for the drug discovery process. Drug Discov Today. 1999;4:55-62. https://doi.org/10.1016/S1359-6446(98)01291-4
  6. Mayr U, Mayr M, Yin X, Begum S, Tarelli E, Wait R, Xu Q. Proteomic dataset of mouse aortic smooth muscle cells. Proteomics. 2005;5:4546-4557. https://doi.org/10.1002/pmic.200402045
  7. Pinet F, Poirier F, Fuchs S, Tharaux PL, Caron M, Corvol P, Michel JB, Joubert-Caron R. Troponin T as a marker of differentiation revealed by proteomic analysis in renal arterioles. FASEB J. 2004;18:585-586. https://doi.org/10.1096/fj.03-0939fje
  8. Won KJ, Lee P, Jung SH, Jiang X, Lee CK, Lin HY, Kang H, Lee HM, Kim J, Toyokuni S, Kim B. 3-morpholinosydnonimine participates in the attenuation of neointima formation via inhibition of annexin A2-mediated vascular smooth muscle cell migration. Proteomics. 2011;11:193-201. https://doi.org/10.1002/pmic.200900834
  9. Lee CK, Han JS, Won KJ, Jung SH, Park HJ, Lee HM, Kim J, Park YS, Kim HJ, Park PJ, Park TK, Kim B. Diminished expression of dihydropteridine reductase is a potent biomarker for hypertensive vessels. Proteomics. 2009;9:4851-4858. https://doi.org/10.1002/pmic.200800973
  10. Lee CK, Kim HJ, Lee YR, So HH, Park HJ, Won KJ, Park T, Lee KY, Lee HM, Kim B. Analysis of peroxiredoxin decreasing oxidative stress in hypertensive aortic smooth muscle. Biochim Biophys Acta. 2007;1774:848-855. https://doi.org/10.1016/j.bbapap.2007.04.018
  11. Hsieh SY, Shih TC, Yeh CY, Lin CJ, Chou YY, Lee YS. Comparative proteomic studies on the pathogenesis of human ulcerative colitis. Proteomics. 2006;6:5322-5331. https://doi.org/10.1002/pmic.200500541
  12. Shkoda A, Werner T, Daniel H, Gunckel M, Rogler G, Haller D. Differential protein expression profile in the intestinal epithelium from patients with inflammatory bowel disease. J Proteome Res. 2007;6:1114-1125. https://doi.org/10.1021/pr060433m
  13. Nagar AB. Isolated colonic ulcers: diagnosis and management. Curr Gastroenterol Rep. 2007;9:422-428. https://doi.org/10.1007/s11894-007-0053-9
  14. Kuhbacher T, Schreiber S, Folsch UR. Ulcerative colitis: conservative management and long-term effects. Langenbecks Arch Surg. 2004;389:350-653. https://doi.org/10.1007/s00423-004-0477-8
  15. Minami M, Hasegawa T, Ando T, Maeda O, Ohkura T, Ohta M, Goto H. Post-colonoscopic Listeria septicemia in ulcerative colitis during immunosuppressive therapy. Intern Med. 2007;46:2023-2027. https://doi.org/10.2169/internalmedicine.46.0303
  16. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med. 1987;317:1625-1629. https://doi.org/10.1056/NEJM198712243172603
  17. Alvares JF, Devarbhavi H, Makhija P, Rao S, Kottoor R. Clinical, colonoscopic, and histological profile of colonic tuberculosis in a tertiary hospital. Endoscopy. 2005;37:351-356. https://doi.org/10.1055/s-2005-861116
  18. Kapoor VK. Abdominal tuberculosis. Postgrad Med J. 1998;74:459-467. https://doi.org/10.1136/pgmj.74.874.459
  19. Vermeulen N, Arijs I, Joossens S, Vermeire S, Clerens S, Van den Bergh K, Michiels G, Arckens L, Schuit F, Van Lommel L, Rutgeerts P, Bossuyt X. Anti-alpha-enolase antibodies in patients with inflammatory Bowel disease. Clin Chem. 2008;54:534-541. https://doi.org/10.1373/clinchem.2007.098368
  20. Zhao X, Kang B, Lu C, Liu S, Wang H, Yang X, Chen Y, Jiang B, Zhang J, Lu Y, Zhi F. Evaluation of p38 MAPK pathway as a molecular signature in ulcerative colitis. J Proteome Res. 2011;10:2216-2225. https://doi.org/10.1021/pr100969w
  21. Roozendaal C, Zhao MH, Horst G, Lockwood CM, Kleibeuker JH, Limburg PC, Nelis GF, Kallenberg CG. Catalase and alpha-enolase: two novel granulocyte autoantigens in inflammatory bowel disease (IBD). Clin Exp Immunol. 1998;112:10-16. https://doi.org/10.1046/j.1365-2249.1998.00528.x
  22. Royds JA, Timperley WR, Taylor CB. Levels of enolase and other enzymes in the cerebrospinal fluid as indices of pathological change. J Neurol Neurosurg Psychiatry. 1981;44:1129-1135. https://doi.org/10.1136/jnnp.44.12.1129
  23. Roine RO, Somer H, Kaste M, Viinikka L, Karonen SL. Neurological outcome after out-of-hospital cardiac arrest. Prediction by cerebrospinal fluid enzyme analysis. Arch Neurol. 1989;46:753-756. https://doi.org/10.1001/archneur.1989.00520430047015
  24. Hay E, Royds JA, Davies-Jones GA, Lewtas NA, Timperley WR, Taylor CB. Cerebrospinal fluid enolase in stroke. J Neurol Neurosurg Psychiatry. 1984;47:724-729. https://doi.org/10.1136/jnnp.47.7.724
  25. Grigoriadis G, Anderson MA, Whitehead S. Charcot-Leyden crystals. Intern Med J. 2010;40:792. https://doi.org/10.1111/j.1445-5994.2010.02353.x
  26. Di Sabatino A, Battista N, Biancheri P, Rapino C, Rovedatti L, Astarita G, Vanoli A, Dainese E, Guerci M, Piomelli D, Pender SL, MacDonald TT, Maccarrone M, Corazza GR. The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease. Mucosal Immunol. 2011;4:574-583. https://doi.org/10.1038/mi.2011.18
  27. Ackerman SJ, Liu L, Kwatia MA, Savage MP, Leonidas DD, Swaminathan GJ, Acharya KR. Charcot-Leyden crystal protein (galectin-10) is not a dual function galectin with lysophospholipase activity but binds a lysophospholipase inhibitor in a novel structural fashion. J Biol Chem. 2002;277:14859-14868. https://doi.org/10.1074/jbc.M200221200
  28. Lin TA, Kourteva G, Hilton H, Li H, Tare NS, Carvajal V, Hang JS, Wei X, Renzetti LM. The mRNA level of Charcot-Leyden crystal protein/galectin-10 is a marker for CRTH2 activation in human whole blood in vitro. Biomarkers. 2010;15:646-654. https://doi.org/10.3109/1354750X.2010.511266
  29. Fujita M, Ichinose S, Kiyono T, Tsurumi T, Omori A. Establishment of latrunculin-A resistance in HeLa cells by expression of R183A D184A mutant beta-actin. Oncogene. 2003;22:627-631. https://doi.org/10.1038/sj.onc.1206173
  30. Nunoi H, Yamazaki T, Tsuchiya H, Kato S, Malech HL, Matsuda I, Kanegasaki S. A heterozygous mutation of betaactin associated with neutrophil dysfunction and recurrent infection. Proc Natl Acad Sci USA. 1999;96:8693-8698. https://doi.org/10.1073/pnas.96.15.8693
  31. Schevzov G, Lloyd C, Gunning P. High level expression of transfected beta- and gamma-actin genes differentially impacts on myoblast cytoarchitecture. J Cell Biol. 1992;117:775-785. https://doi.org/10.1083/jcb.117.4.775

Cited by

  1. Prototype and Chimera-Type Galectins in Placentas with Spontaneous and Recurrent Miscarriages vol.17, pp.5, 2016, https://doi.org/10.3390/ijms17050644
  2. Application of Proteomics to Inflammatory Bowel Disease Research: Current Status and Future Perspectives vol.2019, pp.None, 2012, https://doi.org/10.1155/2019/1426954
  3. Integrated omics profiling of dextran sodium sulfate-induced colitic mice supplemented with Wolfberry ( Lycium barbarum ) vol.4, pp.1, 2020, https://doi.org/10.1038/s41538-020-0065-5